EMILY LEVITT-GOPIE: Open Payments
NPI 1992006217 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 9 payments from 5 companies in 2025. Trend: 2023 $689 · 2024 $433 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $166 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
Products named: Yeztugo, PENMENVY, NEFFY, Wegovy, ROTARIX, MOUNJARO.
Industry payments across HI — which companies pay providers there.
